Ophthalmology in China

Previous Articles     Next Articles

Opportunities and challenges of clinical and basic research on Bietti crystalline dystrophy

Li Yang   

  1. Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing 100005, China
  • Received:2020-02-25 Online:2020-03-25 Published:2020-03-25
  • Contact: Li Yang, Email: yanglibio@aliyun.com
  • Supported by:
    National Key Research and Development Plan of China (2016YFC0905200)

Abstract: Bietti crystalline dystrophy (BCD) is a specific kind of retinitis pigmentoas(RP) and is comparatively common in East Asia, particularly in China and Japan. BCD is inherited in an autosomal recessive inheritance mode and its disease-causing gene is CYP4V2. Majority previously published studies have described the phenotypic and genotypic characterization of BCD, however, we are still unclear on natural history of BCD patients and pathogenesis of BCD, which is very important to determinate time window of BCD gene therapy, evaluate outcome of clinical trials, and explore other treatment. (Ophthalmol CHN, 2020, 29: 84-86)

Key words: Bietti crystalline dystrophy, CYP4V2 gene, mutation